Hospital pharmacists welcome price disclosure recommendations

The SHPA has welcomed the Grattan Institute report’s recommendations on price disclosure The Institute’s conclusion that Australian Government policies have not gone far enough or fast enough to reduce the price of generic medicines no longer covered by patents should be welcomed and acted upon, says the Society of Hospital Pharmacists of Australia. The report,